transplantation-2021

transplantation-2021

 Inviting all the participants over the earth to take part in  International Conference on Transplantation 2021  to be held during Dec 08-09, 2021, which cover prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions.
Transplantation conference 2021  is glad to welcome all the interested and enthusiastic participants across the sphere to its prestigious Conference on Transplantation which goes to be held in Dubai, UAE.
Transplantation 2021 highlights the theme “Create Awareness- Change the ending of someone’s story- Be a Do-er. Be a Donor”. Transplantation 2021 provides a wonderful opportunity to share views, exchange knowledge and establish research collaborations & networking. The most aim of this conference is to exchange new scientific and clinical information within the field of transplantation bringing together the transplant surgeons, physicians, scientists, organ procurement personnel, pharmacologist, nurses, and other allied health professionals under a roof. 

Session 01:  Xenotransplantation
Xenotransplantation has the potential to alleviate the critical shortage of organs for transplantation in humans. However, multiple barriers exist to the broad clinical application of xenotransplantation, including immunologically mediated graft rejection of xenogeneic tissues, metabolic or molecular incompatibilities between donor organs and humans, ethical concerns, and the risk of infections that may be transmitted from donor species to humans.
Transplantation Conferences | Transplantation Conferences | Organ Donation Conferences | Organ Transplantation Conferences.
Session 02: Face and Hand Transplants
Face transplant surgery can restore the physical functionality of a human face, including the ability to breathe, speak, swallow, smile, and show other emotions. There are two major reasons why face transplant surgery should lead to less pain and discomfort. One is that face transplant surgery is one large procedure, whereas conventional face reconstruction involves many surgeries and many recoveries. Another is that face transplant surgery does not involve other surgical sites on the body where the patient’s own skin is removed for use on the face.
World Transplantation Congress | World Transplant Congress | International Transplantation Meeting
Session 03: Retransplantation
Retransplantation is one situation in which alternative techniques to the bicaval anastomosis are especially useful. Retransplantation remains the definitive treatment for this complicated and grave condition. Retransplantation has been utilized as a salvage technique for refractory graft failure. Outcomes following early, emergent retransplantation for primary graft dysfunction are poor, and consequently, use of this intervention in this setting is discouraged.
Heart Transplantation Conferences | Transplantation Conferences  | World Transplantation Congress | Transplant Congress
Session 04: Transplantation immunology
A major problem following transplantation is that the immune system of the recipient sees the grafted tissue as 'foreign' and attacks and destroys it. Historically, the focus of transplant immunology has mainly relied on targeting the mechanisms of specific (adaptive) immunity. However, there are emerging data that both rejection and tolerance are influenced by both nonspecific (innate) and adaptive immune responses.
Transplantation Webinars | Organ Donation Summits |Organ Transplant Meetings | Kidney Transplantation Conferences
Session 05: Experimental transplantation
A transplant experiment is to tests the effect of the environment by moving two species from their native environments into a common environment. The name was originally applied to experiments on plants but is now equally applied to animals such as lizards, ants, and other organisms. Transplant experiments are often used to test if there is a genetic component to differences in populations. Advances in molecular biology have provided researchers with the ability to study genetic variation more directly. However, transplant experiments still have the advantages of being simple and requiring little technology. Common garden methods can be improved by combining evidence with genomic studies, the use of dense marker panel data, and modern statistical methods.
International Transplantation Meetings | Transplant Webinars | Organ Transplant Collaborations | Transplant Liver Conferences
Session 06: Tissue injury and repair
TR is a complex and comprehensive process that encompasses various aspects of tissue rebuilding and is governed by intricate molecular signaling. Not all the tissues in the body are capable of stimulating TR. The so-called ‘post mitotic’ tissues such as muscles and nervous tissue cannot undergo TR while other tissues such as skin, liver, kidney, and lungs are capable of undergoing a TR upon surgical resection, mechanical, or chemical injury.
Organ Donation Conferences | Organ Transplantation Conferences |World Transplant Congress | International Transplantation Conferences.
Session 07: Organ procurement and preservation
The procurement process is a complex series of events that involves medical professionals at all levels in varied settings. Federal and state legislation has been enacted to help ensure that the process is carried out in a fair and efficient way, leading to an equitable distribution of donated organs. UNOS has developed a point system for selecting recipients as objectively as possible. Once the recipients have been identified, they are called in for their preoperative workups.
Organ preservation is the ability to maintain ex vivo organ viability in addition to the capacity to restore normal organ function at the time of restitution of physiological blood flow.
Heart Transplantation Conferences | Transplantation Conferences  | World Transplantation Congress | Transplant Congress | Transplantation Webinars
Session 08: Barriers to transplantation

  • Blood groups. Blood groups represent important transplantation barriers when blood is transfused because incompatible ABO blood group antigens of the donor are recognized by the recipient's natural antibodies. ...
  • Major histocompatibility antigens
  • Minor histocompatibility antigens.

Organ Transplant Meetings | Kidney Transplantation Conferences | International Transplantation Meetings | Transplant Webinars

Session 09:  Living donors and paired exchange
There can be multiple match offers, involving multiple bloods draws for the donor and the uncertainty of failed chains. The timing of the transplant can be unpredictable as it depends on the many centers involved and the possibilities of failed cross matches. A KPE chain may fall apart at the last minute due to health issues of the recipients, resulting in a rollercoaster ride of hope and disappointment. If the donors experience too many of these false starts, they may eventually lose interest in the process.. Depending on the specific paired exchange program used, there may be protections in place to give recipients in these situations priority for future matches. Kidney exchanges are complex and, in spite of everyone’s good intentions, can be difficult to execute. The key to the continued success of kidney exchanges depends on many factors, including improved streamlining of the process. Better record sharing capabilities, improved shipping plans, standardized national financial fees, a thorough informed consent of the donor, would have an impact in improving the exchange process.
Transplantation Conferences | Transplantation Conferences | Organ Donation Conferences | Organ Transplantation Conferences.
Session 10:  Histocompatibility
After receiving a transplant, the recipient's T cells will become activated by foreign MHC molecules on the donor tissue and trigger the immune system to attack the donated tissue The more similar HLA alleles are between donor and recipient, the fewer foreign targets exist on the donor tissue for the host immune system to recognize and attack. The number and selection of MHC molecules to be considered when determining whether two individuals are histocompatible fluctuate based on application, however matching HLA-A, HLA-B, and HLA-DR has been shown to improve patient outcomes. Histocompatibility has a measurable effect on whole organ transplantation, increasing the life expectancy of both the patient and the organ. HLA similarity is therefore a relevant factor when choosing donors for tissue or organ transplant. This is especially important for pancreas and kidney transplants.
International Transplantation Conferences | Organ Donation Webinars | Liver Transplant Conferences | Heart Transplantation Conferences

Session 11: Tolerance
The most commonly transplanted solid organ is the kidney, but the field of solid organ transplantation also includes the heart, liver, pancreas, lung or intestine. Nowadays, transplantation still remains the best solution for organ failure, even in the face of graft rejection.

  • The immune tolerance
  • Central tolerance
  • Peripheral tolerance

Kidney Transplantation Conferences | International Transplantation Meetings | Transplant Webinars | Organ Transplant  Collaborations
Session 12: Pharmacology and immunosuppression
Immunosuppression for organ transplants usually involves triple or quadruple drug treatment. The intensity of immunosuppression is initially high but tends to be reduced to a maintenance level that is determined by individual factors and the type of organ transplant. Immune suppressants in organ transplant are used for:

  • Preventing organ rejection and reverse acute rejection in organ transplantation.
  • Prevent and treat graft-versus-host disease.
  • Minimize the destruction of affected tissues in autoimmune and inflammatory diseases.

International Transplantation Conferences | Organ Donation Webinars |  Liver Transplant Conferences | Heart Transplantation Conferences.

Transplantation Market Growth & Trends
The global transplantation market size is expected to reach USD 26.5 billion by 2028, growing at a CAGR of 11.5%. Growing incidence of organ failure has resulted in high demand for transplantation procedures, which is boosting market growth. Rising demand for transplant products, such as tissue products, immunosuppressants, and organ preservation solutions, is also a major factor driving the market. Many biotechnology and medical device companies are concentrating on the development of advanced transplant products for the management of organ failure.
Thus, technological advancement and the development of novel & improved transplant products, such as surgical instruments, have majorly contributed to the expansion of the market. In addition, the introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane, provides higher benefits during treatment. Furthermore, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports market growth.

                                            

Report Scope:
This report offers forecasts, by product segment, from 2018 through 2024, including supporting analyses for projections. Product segments covered consist of the solid organ (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation (e.g., bone, skin, cornea, heart valve) markets, along with the pharmaceuticals that accompany each market.
Also included are experimental xenografts and artificial organs; tissue transplants; and cell transplants (e.g., bone marrow, cord blood, peripheral blood, islet cell). The report touches on the use of fetal cells, stem cells and altered cancer cells.
The arrangement of this report offers an overview of the key elements in the transplantation process: tissue typing, procurement and preservation, immunosuppressants for solid organ and tissue transplants, and postoperative monitoring. International markets are discussed, and information is provided on industry structure and the regulatory environment.
Within each section are discussions of commercialization opportunities for each segment of the market. New or emerging devices, techniques and pharmaceuticals are highlighted.
Profiles of leading companies involved with solid organ transplantation, tissue transplantation, and alternative technologies are included. The report provides information on company placement within the market and strategic analyses of the companies’ available and emerging products.
An appendix featuring various terms and processes used in transplantation is provided at the end of the report.
This report cites autologous products only in relation to their impact on the market for allografts. It does not include blood products, except for peripheral and umbilical cord blood as a source of stem cells.
By geography, the market has been segmented into the North America, Europe, Asia-Pacific, and Rest of the World regions. Detailed analysis of the market in major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2024.
Transplantation Market Report Highlights:

  • The tissue products segment accounted for the largest revenue share in 2020 due to increased demand for tissue and organ transplant procedures.
  • The tissue products segment is expected to expand further at a significant CAGR from 2021 to 2028 owing to the advancements in transplantation products.
  • The tissue transplant segment held the largest revenue share in 2020 on account of the high demand for tissue transplant procedures worldwide.
  • The transplant centers segment is projected to record the fastest CAGR during the forecast period owing to the rising popularity of these centers for transplant procedures.
  • The hospitals segment dominated the market, in terms of revenue share, in 2020 owing to a large number of transplant procedures performed in hospitals.
  • North America was the leading regional market in 2020 and is projected to maintain its dominance during the forecast period owing to the presence of well-developed healthcare infrastructure in the region.
  • The presence of a large number of research laboratories, biotechnology, and medical device companies in North America is also one of the key factors contributing to the region’s growth.

Impact of COVID 19 on Transplantation Market
COVID19 impact: Market declined by 50% in 2020

 

Pandemic Impact

Post COVID Outlook

Total transplantation procedures were down to around 50% globally during the first and second quarters of 2020.

Surgeons are now able to transplant organs even in COVID-19 recovered patients. However, post-transplantation patients are at higher risk of COVID-19 and the number of procedures is expected to be limited during 2021.

Many of the transplant centers have started solid organ transplants despite the second wave of the pandemic. For COVID-19 patients, the procedures are performed after 4 weeks of infection.

Organ failures related to permanent damage due to COVID, and an increasing geriatric population are the factors expected to fuel the market during the forecast period. The growth rate is expected to be increased by 2-3% as compared to the CAGR forecasted with non-COVID scenario

 Regional Insights:According to the U.S. Department of Health & Human Services, in 2019, there were around 43,201 patients waiting for kidney transplants in the U.S. However, only 23,401 kidney transplant procedures were performed. Moreover, after a transplantation surgery, the recipients are prescribed powerful immunosuppressive drugs; thus, increasing their susceptibility to infectious diseases with their immunity being weakened.
This can hamper the demand for transplantation procedures in many countries amid the global COVID-19 pandemic. In addition, the shortage of resources, such as primary protective equipment, ICU, and blood products, during the pandemic has contributed to the sharp fall in the market revenue in 2020.
Application Type Insights:
Tissue transplantation led the global transplantation market with a share of over 61% in 2020 and the segment will expand further at the fastest CAGR from 2021 to 2028. This is due to the fact that replacement of skin, cornea, bones, heart valves, tendons, nerves, and veins are the most commonly performed procedures worldwide. The escalating number of burn and accident cases is expected to propel the demand for tissue products. According to the European Road Safety Observatory report, there were 102,362 accidental injury cases reported in Spain, thus, creating a demand for tissue transplantation.
The organ transplantation segment is expected to register a significant growth rate of 10.8% during the forecast period. An increasing number of organ transplantations globally as well as the repetitive purchase of immunosuppressants is anticipated to boost the market growth in the near future. For instance, in 2017, globally, around 90,306 kidney transplant procedures were performed.
                                    

North America led the global market in 2020 with a share of over 39% and is expected to maintain its dominance throughout the study period. The presence of well-developed healthcare facilities and several large-scale biotechnology and medical devices companies, such as Arthrex, Inc.; Zimmer Biomet; Medtronic; Novartis AG; and Stryker, in the region are supporting the market growth.
The gap between demand and supply of organs, including kidney, liver, and heart, for transplantation, has increased in the last decade. However, governments and NGOs of various countries are taking initiatives to encourage people to donate organs and save lives. New guidelines and rules for organ donation make the donation process more transparent and easier. The Human Resource & Services Administration launched Hospital Organ Donor Campaign in April 2020. This led to an increase in the number of organ donations from the previous year.
Asia Pacific is projected to be the fastest-growing regional market during the forecast period owing to the extensive research on stem cells to develop in vitro tissue and organs and improving healthcare infrastructure in countries, such as India, Thailand, the Philippines, and Indonesia.
Key Companies & Market Share Insights:
The market is highly fragmented with the presence of many large-, small-, and medium-scale vendors. Major players are involved in new product launches, mergers & acquisitions, and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, in May 2020, AbbVie acquired Allergan to strengthen its product portfolio and distribution channels.
Rising regulatory approvals for allografts, autologous grafts, and other materials along with the development of innovative products, such as 3D bioprinting for tissue and organ regeneration, have led to high demand for transplant products. For instance, in September 2020, Israel-based CollPlant Biotechnologies and United Therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant. Some of the prominent players in the global transplantation market include:

  • Stryker Corp.
  • Medtronic PLC
  • AbbVie Inc.
  • Zimmer Biomet
  • Novartis International AG
  • 21st Century Medicine
  • Biolife Solutions
  • Teva Pharmaceutical
  • Veloxis Pharmaceuticals

Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each sub-segment from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global transplantation market report on the basis of product type, application type, end-use, and region:

  • Product Type Outlook (Revenue, USD Billion, 2016 - 2028)
  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solutions
  • Application Type Outlook (Revenue, USD Billion, 2016 - 2028)
  • Organ Transplant
  • Tissue Transplant
  • End-use Outlook (Revenue, USD Billion, 2016 - 2028)
  • Hospitals
  • Transplant Centers
  • Others
  • Regional Outlook (Revenue, USD Billion, 2016 - 2028)
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Asia Pacific
  • Japan
  • China
  • India
  • Latin America
  • Brazil
  • Mexico
  • Middle East
  • South Africa
  • Saudi Arabia

Top Transplantation Universities Worldwide:
USA:

  • Columbia University, USA 
  • University of California Los Angeles, USA
  • University of California San Diego, USA
  • University of California San Francisco, USA
  • Yale University, USA
  • Duke University, USA
  • Baylor University, USA
  • Boston University, USA
  • Emory University, USA
  • Capella University, USA
  • Johns Hopkins School of Medicine, USA
  • University of North Carolina Chapel Hill, USA
  • New York University, USA
  • University of Chicago, USA
  • Harvard University, USA
  • University of Pittsburgh, USA
  • University of Pennsylvania, USA
  • University of Southern California, USA
  • Vanderbilt University, USA
  • Washington University, USA

Europe:

  • University in Aachen, Germany
  • Sapienza University of Rome, Italy
  • Lubeck University, Germany
  • University in Skovde, Sweden
  • University in Helsinki, Finland
  • Public university in Barcelona, Spain
  • Maastricht University, Netherlands
  • Herdecke University, Germany
  • VU University Amsterdam, Netherlands
  • Magdeburg University, Germany
  • Munster University, Germany
  • Rovira i Virgili University, Spain
  • Radboud University, Netherlands
  • University of Gottingen, Germany
  • Wurzburg University, Germany
  • Tubingen University, Germany
  • Freiburg University, Germany
  • Aalto University, Finland
  • Heidelberg University, Germany
  • University in Pavia, Italy

Asia:

  • National University of Singapore, Singapore
  • Shanghai Jiao Tong University, China
  • Kyoto University, Japan
  • University of Hong Kong, China
  • University of Delhi, India
  • Peking University, China
  • The Hong Kong University of Science and Technology, China
  • Seoul National University, South Korea
  • The Chinese University of Hong Kong, China
  • National Taiwan University, Taiwan
  • Tsinghua University, China
  • Osaka University, Japan
  • Fudan University, China
  • Mahidol University, Taiwan
  • Korea Advanced Institute of Science and Technology, South Korea
  • Yonsei University, South Korea
  • Nanyang Technological University, Singapore

 

International Conference on Transplantation provides liability to all the global emirates to grow your business globally and sell your Research Materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, Instruments.   Breathe life into your products and make moment brand mindfulness with a pennant advertisement arrangement. Make your pennant intuitive to guide individuals to where you need them to go.
Meetings International is providing opportunities to advertise and connect with experts and leaders across the world. 3+ Million Website Visitors, 40000+ Conference Website Visitors, and 1000+ Sessions which confirm the outstanding pool of new users and visitors creating a platform to build your marketplace globally. Meetings International helps you to connect with global clients anywhere at any time via our unrivaled,  worldwide professionals reach. Start promoting your brand today, basically browse our immense scope of custom-fitted, multi-channel publicizing and sponsorship alternatives across print and computerized stages, and select the geology of your intended interest group.
We maintain high quality and ethical standards in the event industry, which makes us unique and better than the rest. Advertisement banners must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
For further queries, connect our conference manager at  healthscience@theexpertsmeet.com; sponsor@meetingsint.com
You can also connect us via WhatsApp: +65 3158 1626

Meetings International is announcing the Young Scientist Awards through the International Conference on Transplantation (Transplantation 2021) which is scheduled in Dubai, UAE during December 08-09, 2021. This transplantation conference focuses on “Decoding the myths and facts of organ transplantation”.
Transplantation 2021 and upcoming conferences will recognize participants who have significantly added value to the scientific community of transplantation and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researchers by meeting experts to exchange and share their experiences at our international conferences.
Transplantation 2021 focuses mainly on xenotransplantation, organ transplantation, retransplantation, transplantation immunology, experimental transplantation, tissue injury and repair, organ procurement, barriers, living donors, histocompatibility, tolerance, and immunosuppression. The transplantation conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, Ph.D. students, and trainees to showcase their research and innovation.
Eligibility:
Young Scientists, faculty members, post-doctoral fellows, Ph.D. scholars, and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.
Benefits:

  • The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
  • Acknowledgement as YRF Awardee.
  • Promotion on the conference website, Young Researcher Awards and certificates.
  • Link on the conference website.
  • Recognition on Meetings Int. Award Page.
  • Chances to coordinate with partners around the world.
  • Research work can be published in the relevant journal without any publication fee.

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentations will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive an award certificate.
  • The awards will be assessed as far as to plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image, and reference

Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication on the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of the award.
Award Announcements:
An official announcement of the recipients will occur after the completion of the Transplantation Conference.

  • Xenotransplantation
  • Face and Hand Transplants
  • Retransplantation
  • Transplantation immunology
  • Experimental transplantation
  • Tissue injury and repair
  • Organ procurement and preservation
  • Barriers to transplantation
  • living donors and paired exchange
  • Histocompatibility
  • Tolerance
  • Pharmacology and Immunosuppression